CINECA IRIS Institutional Research Information System

RIZZONE, Mario Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.077
EU - Europa 3.421
AS - Asia 1.964
SA - Sud America 179
OC - Oceania 75
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.921
CN - Cina 860
IT - Italia 747
SG - Singapore 444
DE - Germania 428
SE - Svezia 356
IE - Irlanda 308
FR - Francia 268
FI - Finlandia 235
GB - Regno Unito 215
JP - Giappone 160
UA - Ucraina 154
CA - Canada 131
BR - Brasile 130
ES - Italia 123
KR - Corea 113
PL - Polonia 108
AT - Austria 107
NL - Olanda 98
IN - India 74
AU - Australia 70
VN - Vietnam 69
BE - Belgio 54
TR - Turchia 51
CH - Svizzera 41
TW - Taiwan 41
HK - Hong Kong 36
ID - Indonesia 32
RU - Federazione Russa 29
PT - Portogallo 25
MX - Messico 20
AR - Argentina 19
DK - Danimarca 19
CL - Cile 18
GR - Grecia 18
BG - Bulgaria 15
RO - Romania 12
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
SN - Senegal 10
IL - Israele 9
SA - Arabia Saudita 9
LB - Libano 8
EG - Egitto 7
IR - Iran 7
SI - Slovenia 7
MY - Malesia 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
EC - Ecuador 5
EU - Europa 5
IS - Islanda 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PH - Filippine 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
HU - Ungheria 4
MA - Marocco 4
PK - Pakistan 4
RS - Serbia 4
ZA - Sudafrica 4
CY - Cipro 3
HR - Croazia 3
KZ - Kazakistan 3
MU - Mauritius 3
BD - Bangladesh 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
PE - Perù 2
SV - El Salvador 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
JM - Giamaica 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
SY - Repubblica araba siriana 1
TG - Togo 1
VE - Venezuela 1
YE - Yemen 1
Totale 10.757
Salva come PNG Salva come JPEG
Città #
Chandler 587
Beijing 434
Dublin 302
Singapore 300
Santa Clara 267
Fairfield 236
Ashburn 218
Torino 200
Houston 184
Redwood City 161
Wilmington 151
Ann Arbor 144
Woodbridge 124
Villeurbanne 121
Nyköping 120
Medford 112
Seattle 111
Princeton 109
Jacksonville 104
Dearborn 101
Cambridge 97
Helsinki 94
Columbus 91
Munich 87
Vienna 86
Warsaw 80
Turin 73
Pisa 66
Milan 61
Dong Ket 51
Boston 50
Shanghai 49
Guangzhou 45
Madrid 38
Boardman 36
New York 31
Hangzhou 30
Jakarta 27
São Paulo 27
Taipei 27
Tokyo 26
Seoul 23
Hong Kong 22
Rome 21
Chengdu 20
London 20
Ottawa 20
Toronto 20
Fremont 19
Santiago 17
Brussels 16
Norwalk 16
Nuremberg 16
Verona 16
Duncan 15
Nanjing 15
San Diego 15
Amsterdam 14
Edinburgh 14
King City 14
Düsseldorf 13
Hebei 13
Istanbul 13
Lachine 13
Paris 13
Chongqing 12
Jinan 12
Los Angeles 12
Wuhan 12
Changsha 11
Chicago 11
Hefei 11
Huntington Station 11
Saint Paul 11
Trento 11
Barcelona 10
Groslay 10
Hamburg 10
Hartlepool 10
Melbourne 10
Ankara 9
Buenos Aires 9
Cincinnati 9
Copenhagen 9
Gent 9
Mumbai 9
Oxford 9
Berlin 8
Fuzhou 8
Minneapolis 8
Napoli 8
Phoenix 8
Polska 8
Pune 8
Renton 8
Silver Spring 8
Sydney 8
Tübingen 8
Valencia 8
Zhengzhou 8
Totale 5.987
Salva come PNG Salva come JPEG
Nome #
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 775
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 671
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 669
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 450
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 355
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 337
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 297
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 278
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 267
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 265
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 253
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 225
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges 213
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 201
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 156
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. 148
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 141
Neurological comorbidity and severity of COVID-19 131
The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: Evidence from a gait analysis study 108
ARGUMENTS IN FAVOUR OF AN EARLIER APPLICATION OF STN-DBS IN THE COURSE OF PARKINSON DISEASE. 104
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 101
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 101
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 96
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 95
3 years comparison between duodopa and Deep Brain Stimulation 93
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 92
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. 92
Unilateral and bilateral subthalamic nucleus stimulation in Parkinson's disease: effects on EMG signals of lower limb muscles during walking 90
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. 89
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 89
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 88
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 85
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease. 84
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 81
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 80
Apomorphine SC treatment in parkinsonian patients with long-term L-dopa syndrome during L-dopa drug holiday. 79
Transdermal rotigotine in dihydropteridine reductase deficiency 79
The dominant subthalamic nucleus: A gait analysis study 79
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological and outcome correlations with the effects of stimulation 79
Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease. 77
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 77
Effect of L-dopa and subthalamic nucleus stimulation on arm and leg swing during gait in Parkinson's Disease. 76
Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety 76
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 75
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 74
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease 73
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. 70
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 70
A new index to assess turning quality and postural stability in patients with Parkinson's disease 70
COVID-19 and Parkinson's Disease: What We Know So Far? 70
Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease 69
Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease 68
Effects of 80 Hz stimulation on gait in STN-DBS treated PD patients 67
COVID-19 in Parkinson's disease: Report on prevalence and outcome 67
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 67
Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson's disease. 65
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters. 64
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 64
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 64
Home monitoring of motor fluctuations in Parkinson’s disease patients 63
Endovascular Treatment for Acute Ischemic Stroke 63
RELAZIONE TRA TARGETING ANATOMICO E NEUROFISIOLOGICO DEL NUCLEO SUBTALAMICO NELLA CHIRURGIA DELLA MALATTIA DI PARKINSON. 62
High-frequency electrical stimulation of the subthalamic nucleus in Parkinson's disease: kinetic and kinematic gait analysis 61
Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results 61
La stimolazione elettrica ad alta frequenza del nucleo subtalamico nel trattamento chirurgico della malattia di Parkinson. 59
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 59
A man with hyponatremia, confusion, and involuntary limb movements 59
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 58
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 58
Peripheral neuropathy in Parkinson’s disease patients treated with duodenal levodopa/carbidopa infusion: A clinical and electrophysiological follow-up study 57
Onset of Covid-19 with impaired consciousness and ataxia: a case report 57
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 56
Quantitative analysis of gait in Parkinson's disease: a pilot study on the effects of bilateral sub-thalamic stimulation. 55
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease 53
Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report 53
Nocturnal problems and sleep benefit in Parkinson’s disease. 52
Neurological comorbidities and COVID-19-related case fatality: A cohort study 52
Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-dopa treatment in Parkinson's disease 50
Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. 50
Parkinson's clinical features after 30 years of disease: A study from patients treated by subthalamic nucleus stimulation 49
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 46
STIMOLAZIONE CEREBRALE PROFONDA DEL NUCLEO SUBTALAMICO : FOLLOW-UP NEUROPSICOLOGICO. 44
Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease 43
Malattia di Parkinson 43
Prospective assessment of peripheral neuropathy in duodopa treated patients 43
Efficacy of subthalamic nucleus stimulation for tremor dystonia: A case report 42
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study 41
I movimenti involontari: tremori e distonie 40
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease 39
Management dei principali effetti collaterali della DBS con esempi di casi DBS problemativi 39
Levodopa-Induced Neuropathy: A Systematic Review 39
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 39
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 36
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 35
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 32
SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke 28
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 28
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 20
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 18
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 16
Totale 11.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.073
article - articoli 0
book - libri 0
conference - conferenze 3.451
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020364 0 0 0 0 0 0 0 0 131 94 84 55
2020/20211.135 108 141 96 58 82 98 68 75 112 93 75 129
2021/20221.207 66 40 54 99 69 45 51 60 41 109 290 283
2022/20231.782 203 165 60 171 147 412 112 119 162 62 109 60
2023/2024874 92 131 40 57 63 94 33 70 17 81 79 117
2024/20251.572 53 122 62 217 516 202 136 198 66 0 0 0
Totale 11.072